Pasadena, California, August 26, 2021
Promis Diagnostics, Inc., announced that it has received an accreditation from the College of American Pathologists (CAP). CAP is a leading organization that fosters and advocates legitimate practice of pathology and laboratory medicine. In receiving this accreditation, Promis Diagnostics proved itself as a state-of-art molecular laboratory in alignment with rigorous CAP standards.
About Promis Diagnostics
Promis Dx has developed and commercialized DNA methylation biomarker-based non-invasive cancer molecular diagnostic products for early detection of cancer (colorectal, lung, bladder cancer, etc.), and is in the process of developing products for companion diagnostics of cancer and various infectious diseases. Based in Pasadena, California, Promis Dx is CAP accredited, CLIA certified, and CDPH licensed laboratory. www.promisdx.com